PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 133 filers reported holding PTC THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 1.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $435,000 | +25.0% | 21,718 | +14.3% | 0.00% | +100.0% |
Q2 2017 | $348,000 | +3.6% | 19,005 | -44.3% | 0.00% | 0.0% |
Q1 2017 | $336,000 | -37.5% | 34,105 | -30.8% | 0.00% | -50.0% |
Q4 2016 | $538,000 | +8.7% | 49,305 | +39.7% | 0.00% | 0.0% |
Q3 2016 | $495,000 | +99.6% | 35,300 | 0.0% | 0.00% | +100.0% |
Q2 2016 | $248,000 | +9.3% | 35,300 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $227,000 | -77.3% | 35,300 | +14.5% | 0.00% | -75.0% |
Q4 2015 | $999,000 | +23.3% | 30,836 | +1.6% | 0.00% | 0.0% |
Q3 2015 | $810,000 | -65.4% | 30,354 | -37.6% | 0.00% | -60.0% |
Q2 2015 | $2,340,000 | -32.0% | 48,614 | -14.0% | 0.01% | -28.6% |
Q1 2015 | $3,442,000 | +14.3% | 56,559 | -2.8% | 0.01% | +7.7% |
Q4 2014 | $3,011,000 | +130.9% | 58,169 | +96.3% | 0.01% | +116.7% |
Q3 2014 | $1,304,000 | +193.0% | 29,630 | +74.1% | 0.01% | +200.0% |
Q2 2014 | $445,000 | +95.2% | 17,021 | +95.3% | 0.00% | +100.0% |
Q1 2014 | $228,000 | +81.0% | 8,714 | +17.8% | 0.00% | 0.0% |
Q4 2013 | $126,000 | +110.0% | 7,398 | +164.2% | 0.00% | – |
Q3 2013 | $60,000 | – | 2,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
Chubb Ltd | 8,180 | $393,000 | 1.68% |